首页> 外国专利> How to treat patients at risk of kidney damage and kidney failure

How to treat patients at risk of kidney damage and kidney failure

机译:如何治疗患者患有肾脏损伤和肾衰竭的患者

摘要

The p21 biomarker is used to assess whether a patient has renal injury or renal failure, and further, renal injury or renal failure by determining the adequacy of initiating one or more renal replacement therapies. How to treat, discontinue delivery of compounds known to damage the kidneys, delay or avoid procedures known to damage the kidneys, and change the administration of diuretics Can be used in.
机译:P21生物标志物用于评估患者是否具有肾损伤或肾功能衰竭,并通过确定启动一个或多个肾替代疗法的充分性来进一步,肾损伤或肾功能衰竭。 如何治疗,停止递送已知损害肾脏的化合物,延迟或避免已知损害肾脏的程序,并且可以使用改变利尿剂的给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号